The Food and Drug Administration is looking into whether three possible health issues or side effects, including hair loss and thoughts of suicide, might be linked to a group of medications that have boomed in popularity for their use in weight loss, including Ozempic, Wegovy, Mounjaro and Zepbound.
The probe into these issues was disclosed Tuesday in a quarterly report by the FDA, which revealed that the agency is investigating reports of alopecia, a hair loss condition; aspiration, a complication during surgery when people inhale food or other objects into their airway; and suicidal ideation in people who used the medications.
…
While issues investigated by the agency sometimes turn out to be little more than false alarms, the agency’s previous probes of reported side effects have also often led to the FDA updating a drug’s labels or precautions, or calling for additional study of the issue.
Couldn’t they just add in: “… For a limited time, we’ll include free hair loss and suicidal thoughts on top of the uncontrollable flatulence, stomach pains, and diarrhea. Call now!!!”
Those marketers need to get creative!
Nurse here, for the record aspiration is not a surgical complication, it can happen anytime someone eats or vomits. I would hazard a guess that the increased vomiting side effect of Ozempic is contributing to aspiration risk.
Would be interesting to see the causality here; could the alopecia be related to malnutrition and suicidality to a mismatch between expected and actual results?
